Scope of Indian Certification of Medical Devices scheme expanded by QCI

Quality Council of India said that this will help in eliminating the circulation and use of sub-standard medical products or devices of doubtful origin that could prove to be serious health hazards.

Published On 2021-06-20 04:00 GMT   |   Update On 2021-11-22 15:59 GMT

New Delhi: The Quality Council of India (QCI) on Friday said the scope of the Indian Certification of Medical Devices scheme has been expanded and it would assist procurement agencies to deal with the issue of counterfeit products and fake certification.The scheme - ICMED 13485 PLUS - has been designed to integrate the quality management system components and product-related quality...

Login or Register to read the full article

New Delhi: The Quality Council of India (QCI) on Friday said the scope of the Indian Certification of Medical Devices scheme has been expanded and it would assist procurement agencies to deal with the issue of counterfeit products and fake certification.

The scheme - ICMED 13485 PLUS - has been designed to integrate the quality management system components and product-related quality validation processes through witness testing of products with reference to the defined product standards and specifications, the council said in a statement.

"This scheme provides the much-needed institutional mechanism for assuring the product quality and safety. It will go a long way in assisting the procurement agencies to tackle the challenges relating to the menace of counterfeit products and fake certification," it added.

It said that this will also help in eliminating the circulation and use of sub-standard medical products or devices of doubtful origin that could prove to be serious health hazards.

Read also: Amid covid surge, Govt facilitates speedy imports of key medical devices

"The QCI and the Association of Indian Manufacturers of Medical Devices (AiMeD) have added further features to the ICMED, the scheme was launched in 2016," it said.

Adil Zainulbhai, Chairman, QCI, said that the agility of the Indian medical device manufacturers to respond effectively to the COVID pandemic encouraged the council to further design an integrated product quality framework to support the industry during these trying times.

Read also: NPPA directs manufacturers to revise MRP of drugs, medical devices in line with new GST rates



Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News